Trader notes, earnings previews, Confluences, weekly digests and roundups — long-form analysis grounded in ORTEX short interest, options flow and analyst data.
Trader Note — 15010 total
BUG — the Global X Cybersecurity ETF — has put in one of its stronger weeks of the year, with the 9% gain since Monday cutting against a backdrop of short sellers quietly trimming exposure. The positioning picture is…
AdaptHealth Corp. has just delivered one of the ugliest single-week drops in the home healthcare equipment sector this year — a 40% plunge that leaves the stock at $6.71 and reframes every prior bull thesis in a matter…
BNTX delivered its Q2 results on August 4 and the market's verdict was swift — the stock slipped roughly 1% on the day and has now shed 6% over the past month, with analysts moving quickly to pare back their price…
Datadog enters the post-earnings session having done exactly what the bullish pre-print setup demanded — the stock closed at $288.15, up 5.3% on the day and 15% on the week, after Q2 results cleared a bar that analysts…
Dynatrace delivered what the pre-earnings setup was pricing in — the stock rose 4.1% on the week to $45.71, and the analyst community wasted no time responding. The most notable post-print move came from BTIG, where…
Red Cat Holdings heads into its August 6 earnings report with a genuinely extreme lending setup — every share available to borrow has been lent out, leaving new short sellers with nowhere to go. The borrow market tells…
CrowdStrike enters the week of August 5 with a sharp divergence at its core: the stock has ripped 16% in five days, analysts are raising targets in a pack, and the CEO is selling into every tick higher. The analyst…
IDEAYA Biosciences heads into the week after reporting earnings with the Street still constructive but quietly trimming targets, while short sellers who spent June building positions have spent July unwinding them. The…
Custom Truck One Source has its clearest post-earnings momentum in months — the Q2 print delivered an 8.6% next-day gain, and two analyst upgrades in as many days have pushed targets above the current price for the…
UBER has just delivered its Q2 results, and the post-earnings picture looks materially different from the defensive crouch that defined positioning heading into the print. The options market spent the final days before…
TransMedics Group closed Tuesday at $80.75, up 5.8% on the week — but that headline gain masks a more complicated story. Analysts filed a wave of target-price cuts within hours of the company reporting earnings on…
PINS delivered what the market wanted: the stock jumped 6% on earnings day and closed the week at $25.58, up 5% on the week and 16% on the month, as a wave of analyst target raises confirmed the print was good enough…
DELL has had a remarkable week — up 19% to $467.27 — yet the short side of the ledger shows almost no sign of stress, creating an unusual divergence between a stock moving hard and a short book that barely…
TOST just delivered its Q2 results and the Street responded with a near-unanimous target raise — the clearest post-earnings analyst reaction the stock has seen in recent memory. Ten firms raised price targets on August…
MQ heads into its August 6 earnings release with short interest near record lows, a lending market that is essentially friction-free, and options positioning that remains firmly tilted toward calls — but the payment…
ARES has delivered its most impressive week in months, jumping nearly 12% after a blowout July 31 earnings print sent the stock to $142.91 — and the question now is whether the analyst upgrades and fading short…
Twist Bioscience heads into the aftermath of its August 3 earnings print with a sharp post-results rally running headlong into one of the most stubborn short positions in biotech. The stock jumped 8.6% on the day of…
Ondas Inc. enters its August 13 earnings print with a striking divergence: the stock is up 13% on the week, yet the short position remains one of the most extreme in the market and the borrow is completely locked. The…
Arvinas heads into the post-earnings week with a split analyst verdict, a stock still trading well below consensus targets, and options positioning that has turned markedly more defensive. The clearest signal this week…
Elanco Animal Health has now printed its Q2 results — the event the market spent last week pricing in — and the question shifts from anticipation to what the data reveals about positioning as the dust settles. The…
